DAIC

APRIL 6, 2024

Gregg Stone, MD “When you examine the outcomes in patients with heart failure across a broad range of left ventricular ejection fraction, the Ventura interatrial shunt was extremely safe but did not improve outcomes compared with no treatment. There was a tremendous placebo effect,” he said.

Heart Failure 81

Heart Failure Quality of Life Outcomes Preserved Ejection Fraction 81

DAIC

FEBRUARY 21, 2024

Getty Images milla1cf Wed, 02/21/2024 - 19:10 February 21, 2024 — Ochsner Children's Hospital , ranked among the top hospitals in the nation for pediatric cardiology and congenital heart surgery, is raising awareness of the need for more pediatric-specific heart devices. Yet, research and innovation in this field has not kept pace.

Pediatrics 105

Pediatrics Hospital Heart Failure Transplant 105

DAIC

MARCH 13, 2024

In the subgroup of patients targeted in the CardiAMP Heart Failure II Trial, results showed large absolute and relative risk reduction of heart death equivalents of the patients in the treated group. Treated patients also had reduced major adverse cardiac events and greatly improved quality of life. “We

CMS 111

CMS Heart Failure Reimbursement Quality of Life 111

DAIC

APRIL 6, 2024

Gregg Stone, MD “When you examine the outcomes in patients with heart failure across a broad range of left ventricular ejection fraction, the Ventura interatrial shunt was extremely safe but did not improve outcomes compared with no treatment. There was a tremendous placebo effect,” he said.

Heart Failure 75

Heart Failure Quality of Life Preserved Ejection Fraction Hospital 75

European Journal of Heart Failure

NOVEMBER 11, 2024

Aims Timely referrals for transplantation and left ventricular assist device (LVAD) play a key role in favourable outcomes in patients with advanced heart failure (HF). Cardiovascular mortality, driven by sudden cardiac death, is the main reason for dying while waiting for heart transplantation (HTx).

Heart Transplant 40

Heart Transplant Transplant Heart Failure Ablation 40

European Journal of Heart Failure

DECEMBER 1, 2024

Summary of key study outcomes. 5+) support is effective in facilitating heart recovery, overall survival, and quality of life. Methods and results This single-centre retrospective study examined midterm (180 days) outcomes of patients with CS supported by Impella 5+ who achieved heart recovery.

Cardiogenic Shock 40

Cardiogenic Shock Heart Transplant Outcomes Transplant 40

Dr. Sanjay Gupta

MARCH 6, 2022

If we are unable to build a relationship of trust with the patient then we are going to fail in achieving the best outcome for that patient and this is why engagement and empathy are so essential. Medications that improve quality of life in heart failure for example include diuretics.

Chronic Disease 40

Chronic Disease Quality of Life Heart Failure Nursing 40